These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8896658)

  • 21. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is sublingual nifedipine administration superior to oral administration in the active treatment of hypertension?
    Diker E; Ertürk S; Akgün G
    Angiology; 1992 Jun; 43(6):477-81. PubMed ID: 1595942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency.
    Ambroso GC; Como G; Scalamogna A; Citterio A; Casati S; Ponticelli C
    Clin Nephrol; 1985 Jan; 23(1):41-5. PubMed ID: 3978881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
    Ragueneau I; Sao AB; Démolis JL; Darné B; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2001 Mar; 69(3):122-9. PubMed ID: 11240976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual nifedipine in hypertensive emergencies with special reference to cerebrovascular accident.
    Gambhir IS; Gupta SS; Singh DS
    J Indian Med Assoc; 1991 Aug; 89(8):231-4. PubMed ID: 1748801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sublingual nifedipine in hypertensive emergencies.
    Ellrodt AG; Ault MJ; Riedinger MS; Murata GH
    Am J Med; 1985 Oct; 79(4A):19-25. PubMed ID: 4050842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose sublingual nifedipine as the only treatment in hypertensive urgencies and emergencies.
    González-Carmona VM; Ibarra-Pérez C; Jerjes-Sánchez C
    Angiology; 1991 Nov; 42(11):908-13. PubMed ID: 1952278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate management of severe hypertension.
    Ram CV
    Cardiol Clin; 1995 Nov; 13(4):579-91. PubMed ID: 8565021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the calcium-channel blocker nifedipine in the management of hypertensive emergency.
    Haft JI
    Am J Emerg Med; 1985 Dec; 3(6 Suppl):25-30. PubMed ID: 4084379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation and management of patients with uncontrolled, severe hypertension: results from a public teaching hospital.
    Preston RA; Baltodano NM; Cienki J; Materson BJ
    J Hum Hypertens; 1999 Apr; 13(4):249-55. PubMed ID: 10333343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertensive crisis associated with nifedipine withdrawal.
    Bursztyn M; Tordjman K; Grossman E; Rosenthal T
    Arch Intern Med; 1986 Feb; 146(2):397. PubMed ID: 3947200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing inappropriate prescribing of sublingual nifedipine.
    Yasuda SU; Woosley RL
    J Pharm Technol; 1995; 11(1):21-2. PubMed ID: 10140714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on improvement of pharmaceutical preparations prescribed in hospitals. V. Nifedipine hollow type suppository.
    Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Tamura H; Yuasa H; Kanaya Y
    Drug Des Deliv; 1986 Nov; 1(2):167-73. PubMed ID: 3509330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.